Seelos Therapeutics Inc SEEL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/03/21 EDT
2.11quote price arrow up+2.11 (UNCH)
Volume
14,613
Close
2.09quote price arrow down-0.11 (-5.00%)
Volume
1,683,905
52 week range
0.56 - 6.60

...

Loading . . .
  • Open2.17
  • Day High2.18
  • Day Low2.07
  • Prev Close2.09
  • 52 Week High6.60
  • 52 Week High Date04/27/21
  • 52 Week Low0.56
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap212.82M
  • Shares Out101.83M
  • 10 Day Average Volume1.74M
  • Dividend-
  • Dividend Yield-
  • Beta3.07
  • YTD % Change32.28

KEY STATS

  • Open2.17
  • Day High2.18
  • Day Low2.07
  • Prev Close2.09
  • 52 Week High6.60
  • 52 Week High Date04/27/21
  • 52 Week Low0.56
  • 52 Week Low Date09/24/20
  • Market Cap212.82M
  • Shares Out101.83M
  • 10 Day Average Volume1.74M
  • Dividend-
  • Dividend Yield-
  • Beta3.07
  • YTD % Change32.28

RATIOS/PROFITABILITY

  • EPS (TTM)-0.57
  • P/E (TTM)-3.68
  • Fwd P/E (NTM)-4.42
  • EBITDA (MRQ)-29.862M
  • ROE (MRQ)-211.80%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)79.21%
  • Net Margin (MRQ)-5,984.27%
  • Debt To Equity (MRQ)22.39%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Seelos Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Seelos Therapeutics, Inc., formerly Apricus Biosciences, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing technologies and therapeutics for the treatment of central nervous system, respiratory disorders. The Company is engaged in developing its lead programs SLS-002 and SLS-006. The Company is also engaged in developing several preclinical programs, which include SLS-008, SLS-007 SLS-010 and SLS-012. SLS-002 is intranasal racemic...
Raj Mehra
Chairman
Address
300 PARK AVENUE, 2ND FLOOR
New York, NY
10022
United States

Top Peers

SYMBOLLASTCHG%CHG
ZYNE
Zynerba Pharmaceuticals Inc
4.44-0.06-1.33%
INFI
Infinity Pharmaceuticals Inc
2.66-0.27-9.22%
SCPH
scPharmaceuticals Inc
5.37-0.09-1.65%
GTBP
GT Biopharma Inc
10.72-0.54-4.80%
CRMD
CorMedix Inc
5.90-0.11-1.83%